Risk factors for ulcerative colitis associated colorectal cancers in a Hungarian cohort of ulcerative colitis patients. Result of a population based study;A colorectális rák rizikófaktorai colitis ulcerosás betegekben populációs alapú vizsgálat eredményei alapján

Orvosi Hetilap

Volumn 147, Issue 4, 2006, Pages 175-181

  Lakatos, László ^a   Mester, Gábor ^a   Erdélyi, Zsuzsanna ^a   David, Gyula ^a   Pandúr, Tünde ^a   Balogh, Mihály ^a   Fischer, Simon ^b   Vargha, Péter ^b   Lakatos, Péter László ^b  

^a I Belgyógyśzati Osztály ^*  (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Colorectal cancer; IBD; Primary sclerosing cholangitis; Ulcerative colitis

Indexed keywords

ACETYLSALICYLIC ACID; AZATHIOPRINE; STEROID;

ADOLESCENT; ADULT; AGED; ANEMIA; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RISK; CANCER SURVIVAL; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL STUDY; COHORT ANALYSIS; COLON CARCINOGENESIS; COLON RESECTION; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; DATA BASE; DISEASE DURATION; DISEASE SEVERITY; DYSPLASIA; EPIDEMIOLOGICAL DATA; FAMILIAL DISEASE; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; HUNGARY; IRON DEFICIENCY; LOGISTIC REGRESSION ANALYSIS; MALE; ONSET AGE; POPULATION RESEARCH; PREVALENCE; PRIMARY SCLEROSING CHOLANGITIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SURVIVAL TIME; ULCERATIVE COLITIS; COLORECTAL TUMOR; IRON DEFICIENCY ANEMIA; MIDDLE AGED; PATHOLOGY; SCLEROSING CHOLANGITIS; STATISTICAL MODEL; TIME;

ADULT; AGED; ANEMIA, IRON-DEFICIENCY; CHOLANGITIS, SCLEROSING; CHRONIC DISEASE; COHORT STUDIES; COLITIS, ULCERATIVE; COLORECTAL NEOPLASMS; FEMALE; HUMANS; HUNGARY; LOGISTIC MODELS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 33645650105     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Anderson, J. C., Attam, R., Alpern, Z. és mtsai: Prevalence of colorectal neoplasia in smokers. Am. J. Gastroenterol., 2003, 98, 2777-2783.
2. Askling, J., Dickman, P. W., Karlén, P. és mtsai: Family history as a risk factor for colorectal cancer in inflammatory bowel disease. Gastroenterology, 2001, 120, 1356-1362.
3. Bernstein, C. N., Eaden, J., Steinhart, A. H. és mtsai: Cancer prevention in inflammatory bowel disease and chemoprophylactic potential of 5-aminosalicylic acid. Inflamm. Bowel Dis., 2002, 8, 356-361.
4. Crohn, B., Rosenberg, H.: The sigmoidoscopic picture of chronic ulcerative colitis (non-specific). Am. J. Med. Sci., 1925, 170, 220-228.
5. Demográfiai évkönyv 2002. KSH, Budapest, 2003.
6. Eaden, J. Review article: colorectal carcinoma and inflammatory bowel disease. Aliment. Pharmacol. Ther., 2004, 20 (Suppl. 4), 24-30.
7. Eaden, J.: Review article: the data supporting a role for aminosalicylates in the chemoprevention of colorectal cancer in patients with inflammatory bowel disease. Aliment. Pharmacol. Ther., 2003, 18 (Suppl. 2), 15-21.
8. Eaden, J. A., Abrams, K., Mayberry, J. F.: The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut, 2001, 48, 526-535.
9. Ekbom, A., Helmick, C., Zack, M. és mtsa: Ulcerative colitis and colorectal cancer. N. Engl. J. Med., 1990, 323, 1228-1233.
10. Fuszek, P. Horváth, H., Papp, J. és mtsai: No change in location of colorectal cancer between 1993-2004 in Hungarian patients. Z. Gastroenterol., 2005, 43, 485.
11. Greenstein, A. J., Sachar, D. B., Smith, H. és mtsai: Cancer in universal and left-sided ulcerative colitis: factors determining risk. Gastroenterology, 1979, 77, 290-294.
12. Heuschen, U. A., Hinz, U., Allemeyer, E. H. és mtsai: Backwash ileitis is strongly associated with colorectal carcinoma in ulcerative colitis. Gastroenterology, 2001, 120, 841-847.
13. Itzkowitz, S. H., Harpaz, N.: Diagnosis and management of dysplasia in patients with inflammatory bowel disease. Gastroenterology, 2004, 126, 1634-1648.
14. Itzkowitz, S. H., Present, D. H., for the Crohn's and Colitis Foundation of America Colon Cancer in IBD Study Group: Consensus conference: colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm. Bowel. Dis., 2005, 11, 314-321.
15. Kandiel, A., Fraser, A. G., Korelitz, B. I. és mtsai: Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine. Gut, 2005, 54, 1121-1125.
16. Karlén, P., Löfberg, R., Broström, O. és mtsai: Increased risk of cancer in ulcerative colitis: a population-based cohort study. Am. J. Gastroenterol., 1999, 94, 1047-1052.
17. Korelitz, B. I., Mirsky, F. J., Fleisher, M. R. és mtsai: Malignant neoplasms subsequent to treatment of inflammatory bowel disease with 6-mercaptopurine. Am. J. Gastroenterol., 1999, 94, 3248-3253.
18. Kornfeld D, Ekbom A, Ihre T.: Is there an excess risk for colorectal cancer in patients with ulcerative colitis and concomittant primary sclerosing cholangitis? A population based study. Gut, 1997, 41, 522-525.
19. Lakatos L., Mester G., Erdélyi Z. és mtsai: A gyulladásos bélbetegségek epidemiológiája Veszprém megyében - 25 éves felmérés eredményei (1977-2001). Orv. Hetil., 2003, 144, 1819-1827.
20. Lakatos, L., Pandur, T, David, G. és mtsai: Associaton of extraintestinal manifestations of inflammatory bowel disease (IBD) in a province of Western Hungary with disease phenotype: results of a 25-year follow-up study. World J. Gastroenterol., 2003, 9, 2300-2307.
21. Langholz, E., Munkholm, P., Davidsen, M. és mtsai: Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology, 1992, 103, 1444-1451.
22. Lashner, B. A., Heidenreich, P. A., Su, G. L. és mtsai: Effect of folate supplementation on the incidence of dysplasia and cancer in chronic ulcerative colitis. Gastroenterology, 1989, 97, 255-259.
23. Lennard-Jones, J. E., Morson, B. C., Ritchie, J. K. és mtsa.: Cancer surveillance in ulcerative colitis. Experience over 15 years. Lancet, 1983, ii, 149-152.
24. Lennard-Jones, J. E. Classification of inflammatory bowel disease. Scand. J. Gastroenterol., 1989, 24 (Suppl. 170.), 2-6.
25. Lewis, J. D., Bilker, W. B., Brensinger , C. és mtsai: Inflammatory bowel disease is not associated with an increased risk of lymphoma. Gastroenterology, 2001, 121, 1080-1087.
26. Loftus, E. V. Jr, Sandborn, W. J., Tremaine, W. J. és mtsai: Risk of colorectal neoplasia in patients with primary sclerosing cholangitis. Gastroenterology, 1996, 110, 432-440.
27. Maratka, Z., Nedbal, J., Kocianova, J. és mtsai: Incidence of colorectal carcinoma in pancolitis: a retrospective study of 959 cases over 40 years. Gut, 1985, 26, 43-49.
28. Mayer, R., Wong, W D., Rothenberger, D. A. és mtsai: Colorectal cancer in inflammatory bowel disease. Dis. Colon. Rectum, 1999, 42, 343-347.
29. McGovern, D. P. B., Jewell, D. P.: Risk and benefits of azathioprine therapy. Gut, 2005, 54, 1055.
30. Munkholm, P.: Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease. Aliment. Pharmacol. Ther., 2003, 18 (Supp. 12.), 1-5.
31. Ottó Sz., Kásler M.: Rákmortalitás és - incidencia hazánkban, az európai adatok tükrében. Magy. Onkol., 2002, 46, 111-117.
32. Pinczowski, D., Ekbom, A., Baron, J. és mtsai: Risk factors for colorectal cancer in patients with ulcerative colitis: a case control study. Gastroenterology, 1994, 107, 117-120.
33. Rhodes, J. M., Campbell, B. J.: Unifying hypothesis for inflammatory bowel disease and related colon cancer: sticking the pieces together with sugar. Trends in Mol. Med., 2002, 8 , 10-16.
34. Rutter, M., Saunders, B., Wilkinson, K. és mtsai: Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology, 2004, 126, 451-459.
35. Ryan, B. M., Russel, M. G. V. M., Langholz, E. és mtsa: Ammosalicylates and colorectal cancer in IBD: a not-so bitter pill to swallow. Am. J. Gastroenterol., 2003, 98, 1682-1687.
36. Shanahan, F.: Review article: colitis associated cancer - time for new strategies. Aliment. Pharmacol. Ther., 2003, 18 (Suppl. 2), 6-9.
37. Shetty, K., Ribicki, L., Brzezinski, A. és mtsai: The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis. Am. J. Gastroenterol., 1999, 94, 1643-1649.
38. Tung, B. Y., Emond, M. J., Haggitt, R. C. és mtsai: Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Ann. Intern. Med., 2001, 134, 89-95.